Epizyme (EPZM) PT Lowered to $10 at Morgan Stanley
Tweet
Share
E-mailGet Alerts EPZM Hot Sheet
Price: $1.47 --0%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 13
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 13
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz lowered the price target on Epizyme (NASDAQ: EPZM) to $10.00 (from $11.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Berenberg Downgrades PolyPeptide Group AG (PPGN:SW) to Hold
- HA Sustainable Infrastructure Ca (HASI) PT Lowered to $45 at BofA Securities
- Lotus Bakeries (LOTB:BB) PT Raised to EUR11,180 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
